- Royal Brisbane and Women's Hospital acquisition is intended to expand access to potentially life-saving radiotherapy treatments to more patients - Hospital was the first in Australia to invest in the TomoTherapy® helical radiotherapy delivery platform and is now the first to secure the latest generation Radixact® System SUNNYVALE, Calif., Feb. 15, 2022 /PRNewswire/ Accuray Incorporated (NASDAQ:.
/PRNewswire/ Accuray Incorporated (NASDAQ: ARAY) announced today that data from a phase III, randomized controlled trial, TomoBreast, indicate post-surgery.
/PRNewswire/ Accuray Incorporated (NASDAQ: ARAY) announced today that data from a phase III, randomized controlled trial, TomoBreast, indicate post-surgery.